Skip to main content
. 2018 Feb 7;3(1):25–34. doi: 10.1016/j.jacbts.2017.10.001

Table 2.

Plasma Furosemide Noncompartmental PK Parameters Following IV Administration

Cmax (ng/ml) Tmax (h) AUClast (h ∙ ng/ml) AUC (h ∙ ng/ml) AUCext (%) λz (1/h) t½ (h) V (l) CL (l/h)
n 15 15 15 15 15 15 15 15 15
Mean 8,580 N/A 13,000 13,200 0.912 0.277 2.55 24.4 6.71
SD 2,540 N/A 4050 4,170 0.631 0.0365 0.339 9.15 2.31
% CV 29.5 N/A 31.1 31.6 69.2 13.2 13.3 37.5 34.5
Geometric mean 8,270 N/A 12,400 12,600 0.729 0.274 2.53 23.2 6.37
Geometric % CV 28.4 N/A 33.3 33.7 82.2 13.3 13.3 31.2 33.7
Minimum 5,060 0.08 6,540 6,600 0.199 0.218 2.00 15.8 3.83
Median 8,230 2.08 12,800 12,900 0.666 0.275 2.52 23.0 6.20
Maximum 13,800 2.08 20,500 20,900 2.47 0.347 3.18 53.1 12.1

λz = apparent terminal phase elimination rate constant; AUC = area under the curve; AUC = plasma concentration to infinity; AUCext = percentage of AUC that is extrapolated beyond the last measurable concentration; AUClast = last measurable plasma concentration; CL = systemic clearance; Cmax = peak plasma concentration; CV = coefficient of variation; N/A = not available; t½ = terminal phase elimination half-life; Tmax = time to peak plasma concentration; V = systemic volume of distribution.